Skip to content

Preemptive Analgesic Efficacy of Parecoxib for Reducing Postoperative Pain in Gynecological Surgery

Preemptive Analgesic Efficacy of Parecoxib for Reducing Postoperative Pain in Gynecological

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06140238
Enrollment
178
Registered
2023-11-18
Start date
2023-09-10
Completion date
2024-06-27
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological Surgery, Parecoxib, Postoperative Pain, Preemptive Analgesia

Keywords

Preemptive analgesia, Gynecological surgery, Parecoxib, Postoperative pain

Brief summary

The research is to test the preemptive analgesic efficacy of Parecoxib drug in gynecological surgery by comparing Parecoxib drug and NSS administration 15 min before starting the surgery which the result of postoperative pain score is interpret by visual analog scale index

Detailed description

The research is working on testing the preemptive analgesic efficacy of Parecoxib drug in gynecological surgery whether its can reduce postoperative pain score, reduce total opioid consumption in first 24 hour postoperation and reduce postoperation hospital length stay. Patients who are undergoing gynecological surgery is recruited to the research project while they admit in the hospital for preoperative preparation, in each type of surgery groups (1.Total abdominal hysterectomy 2. Adnexal surgery 3. Surgical staging) will divided in to 2 groups which is experimental group (Parecoxib) and control group (Normal saline). The experimental group will have Parecoxib administration 15 min before starting the surgery and control group will have normal saline administration 15 min before starting the surgery as same, the primary result is postoperative pain score which is interpreted by Visual analog scale index at 2,6,12,24 hour postoperation, the patients will get opioid drug (Morphine) for pain control depending on pain score index they inform, if pain score \>7: morphine 0.075 mg/kg iv, if pain score 5 : morphine 0.05mg/kg iv, if pain score \<5 : no morphine given. Lastly the side effect of Parecoxib drug will be observed and postoperative hospital length stay of each patient will be recorded

Interventions

DRUGParecoxib

Parecoxib administration 15 minutes before start surgical operation

DRUGNormal saline

Normal saline administration 15 minutes before start surgical operation

Sponsors

Department of Medical Services Ministry of Public Health of Thailand
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Female patients age between 18-70 year-old, who participate in explor lap gynecological surgery (Hysterectomy, Adnexal surgery and surgical stagings) using general anesthesia technique * American society of Anesthesiologists physical status grade I-II * Capable to communicate in Thai language

Exclusion criteria

* Allergic to NSAIDs and opioid * Allergic to Parecoxib drug * Underlying neuropathic pain * Pregnant woman or woman who undergoes breast feeding * Uncontrolled hypertension disease, BP \>160/110 at admission date * Underlying ischemic heart disease, Ischemic stroke or peripheral arterial disease * History status post coronary artery bypass grafting * Patients who take Aspirin within 7 days before surgery date * Had underlying which is contraindiated to NSAIDs drug such as Gastritis, history of GI ulcer, chronic kidney disease (Cr clearance \< 30ml/min), liver cirrhosis (Child-Pugh class B or above/ serum albumin \< 25 g/l) * Patients who had NSAIDs drug while admit in hospital for preparing the operation before surgery date

Design outcomes

Primary

MeasureTime frameDescription
Post operative pain score24 hour post operationPost operative pain score at 2,6,12,24 hr, described by 'Visual analog pain scale'

Secondary

MeasureTime frameDescription
Total dose of opioid drug consumption24 hour post operationTotal dose of opioid drug consumption (Morphine) in 24 hour post operation

Other

MeasureTime frameDescription
Side effect from Parecoxib drug24 hour post operationobserve any side effects of Parecoxib drug which are nausea, vomit and respiratory depression
Total hospital length stay after operationPost operation date to discharge daterecord total hospital length stay since post operation date to discharge date

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026